Candida Albicans in Syrian Patients With Periodontitis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAl-Hawash Private University
About this trial
Periodontitis is a significant oral health issue characterized by inflammation and destruction of the supporting structures of the teeth. Recent research has indicated that Candida albicans, a common fungal pathogen, may play a role in the exacerbation of periodontal diseases. This study aims to investigate the prevalence and impact of Candida albicans in Syrian patients diagnosed with periodontitis, contributing to a better understanding of its role in oral health within this population.
Eligibility criteria
Qualifiers
Patients aged 18 years and older.
Diagnosed with chronic periodontitis based on clinical examination (attachment loss, probing depth).
Consent to participate in the study.
Disqualifiers
Patients with systemic diseases affecting oral health (e.g., diabetes, immunosuppressive conditions).
Recent antibiotic or antifungal treatment within the last three months.
Trial design
Treatments tested in this trial
- Periodontal Assessment and Sample Collection from Subgingival Pockets
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov